VYCOR MEDICAL, INC.: 10-Q filed 2022-11-14

Name: VYCOR MEDICAL, INC.: 10-Q filed 2022-11-14
Creator: VYCOR MEDICAL, INC.

What VYCOR MEDICAL, INC. reported in its quarterly report filed 2022-11-14 (fiscal Q3 2022): 43 published measures, 115 facts as tagged in accession 0001493152-22-031733.

This filing

Form: 10-Q (quarterly report)
Filed: 2022-11-14
Fiscal period: fiscal Q3 2022
Accession: 0001493152-22-031733 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All VYCOR MEDICAL, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2022-09-30	949,816	USD
At 2021-12-31	935,364	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2022-09-30	3,769,318	USD
At 2021-12-31	3,330,577	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2022-09-30	-2,819,502	USD
At 2022-06-30	-2,599,297	USD
At 2021-12-31	-2,395,213	USD
At 2021-09-30	-2,260,114	USD
At 2021-06-30	-2,178,768	USD
At 2020-12-31	-1,981,316	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2022-09-30	32,570	USD
At 2021-12-31	90,941	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	-114,807	USD	92
2022-01-01 to 2022-09-30	-288,369	USD	273
2021-07-01 to 2021-09-30	3,693	USD	92
2021-01-01 to 2021-09-30	-248,600	USD	273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	-183,662	USD	273
2021-01-01 to 2021-09-30	-10,084	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	3,102	USD	273
2021-01-01 to 2021-09-30	38,690	USD	273

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	309,969	USD	92
2022-01-01 to 2022-09-30	951,725	USD	273
2021-07-01 to 2021-09-30	332,087	USD	92
2021-01-01 to 2021-09-30	1,119,263	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	128,392	USD	273
2021-01-01 to 2021-09-30	81,340	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	-3,102	USD	273
2021-01-01 to 2021-09-30	-38,690	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2022-09-30	-32,309,881	USD
At 2021-12-31	-31,697,142	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	31,997,281	shares	92
2022-01-01 to 2022-09-30	31,432,040	shares	273
2021-07-01 to 2021-09-30	30,219,556	shares	92
2021-01-01 to 2021-09-30	29,249,192	shares	273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	-0.01	USD/shares	92
2022-01-01 to 2022-09-30	-0.02	USD/shares	273
2021-07-01 to 2021-09-30	-0.01	USD/shares	92
2021-01-01 to 2021-09-30	-0.02	USD/shares	273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2022-09-30	319,422	USD
At 2021-12-31	362,393	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	187,381	USD	273
2021-01-01 to 2021-09-30	284,102	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	-88,045	USD	92
2022-01-01 to 2022-09-30	-215,318	USD	273
2021-07-01 to 2021-09-30	-88,396	USD	92
2021-01-01 to 2021-09-30	-271,756	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2022-09-30	579,794	USD
At 2021-12-31	487,411	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2016-10-29 to 2016-10-31	12,000	EUR	3
2012-06-29 to 2012-06-30	12,000	EUR	2
2016-10-29 to 2016-10-31	13,200	USD	3
2012-06-29 to 2012-06-30	13,200	USD	2

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2022-09-30	3,622,248	USD
At 2021-12-31	3,149,997	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2022-09-30	219,007	USD
At 2021-12-31	227,720	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2022-09-30	180,558	USD
At 2021-12-31	126,096	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	355,815	USD	92
2022-01-01 to 2022-09-30	1,063,550	USD	273
2021-07-01 to 2021-09-30	385,338	USD	92
2021-01-01 to 2021-09-30	1,288,069	USD	273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2022-09-30	267,542	USD
At 2021-12-31	207,521	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	267,770	USD	92
2022-01-01 to 2022-09-30	848,232	USD	273
2021-07-01 to 2021-09-30	296,942	USD	92
2021-01-01 to 2021-09-30	1,016,313	USD	273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	341,256	USD	92
2022-01-01 to 2022-09-30	1,019,693	USD	273
2021-07-01 to 2021-09-30	365,785	USD	92
2021-01-01 to 2021-09-30	1,230,340	USD	273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2021-07-01 to 2021-09-30	1,825	USD	92
2021-01-01 to 2021-09-30	8,454	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2022-09-30	32,527,172	shares
At 2021-12-31	30,818,367	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2022-09-30	29,360,447	USD
At 2021-12-31	29,172,169	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2022-09-30	127,675	USD
At 2021-12-31	127,674	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2022-09-30	44,600	USD
At 2021-12-31	79,560	USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

Period	Value	Unit	Days
At 2022-09-30	44,600	USD
At 2021-12-31	77,495	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2022-09-30	98,244	USD
At 2021-12-31	62,473	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	-112,312	USD	92
2022-01-01 to 2022-09-30	-283,835	USD	273
2021-07-01 to 2021-09-30	7,659	USD	92
2021-01-01 to 2021-09-30	-222,145	USD	273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	-114,806	USD	92
2022-01-01 to 2022-09-30	-288,368	USD	273
2021-07-01 to 2021-09-30	3,697	USD	92
2021-01-01 to 2021-09-30	-248,594	USD	273

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	-276,992	USD	92
2022-01-01 to 2022-09-30	-612,739	USD	273
2021-07-01 to 2021-09-30	-158,492	USD	92
2021-01-01 to 2021-09-30	-572,970	USD	273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	46,073	USD	273
2021-01-01 to 2021-09-30	41,665	USD	273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2021-01-01 to 2021-09-30	8,983	USD	273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2022-07-01 to 2022-09-30	-24,267	USD	92
2022-01-01 to 2022-09-30	-68,517	USD	273
2021-07-01 to 2021-09-30	96,055	USD	92
2021-01-01 to 2021-09-30	49,611	USD	273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	6,579	USD	273
2021-01-01 to 2021-09-30	2,193	USD	273

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	0	USD	273
2021-01-01 to 2021-09-30	0	USD	273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	54,462	USD	273
2021-01-01 to 2021-09-30	17,646	USD	273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	71,381	USD	273
2021-01-01 to 2021-09-30	49,838	USD	273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2022-01-01 to 2022-09-30	-8,713	USD	273
2021-01-01 to 2021-09-30	9,468	USD	273

Inspect the source

Entity: VYCOR MEDICAL, INC. / CIK 0001424768
Captured: 2026-09-20T08:03:40.055Z
SEC response SHA-256: 5a14e6ff2e4ebac913c15e977f951bb2964df57677e781dac80300af4dfd59db

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001424768.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))